Cargando…

Pneumocystis jirovecii Pneumonia in Tropical and Low and Middle Income Countries: A Systematic Review and Meta-Regression

OBJECTIVE: Pneumocystis jirovecii pneumonia (PCP), the commonest opportunistic infection in HIV-infected patients in the developed world, is less commonly described in tropical and low and middle income countries (LMIC). We sought to investigate predictors of PCP in these settings. DESIGN: Systemati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowe, David M., Rangaka, Molebogeng X., Gordon, Fabiana, James, Chris D., Miller, Robert F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732248/
https://www.ncbi.nlm.nih.gov/pubmed/23936365
http://dx.doi.org/10.1371/journal.pone.0069969
_version_ 1782279242330931200
author Lowe, David M.
Rangaka, Molebogeng X.
Gordon, Fabiana
James, Chris D.
Miller, Robert F.
author_facet Lowe, David M.
Rangaka, Molebogeng X.
Gordon, Fabiana
James, Chris D.
Miller, Robert F.
author_sort Lowe, David M.
collection PubMed
description OBJECTIVE: Pneumocystis jirovecii pneumonia (PCP), the commonest opportunistic infection in HIV-infected patients in the developed world, is less commonly described in tropical and low and middle income countries (LMIC). We sought to investigate predictors of PCP in these settings. DESIGN: Systematic review and meta-regression. METHODS: Meta-regression of predictors of PCP diagnosis (33 studies). Qualitative and quantitative assessment of recorded CD4 counts, receipt of prophylaxis and antiretrovirals, sensitivity and specificity of clinical signs and symptoms for PCP, co-infection with other pathogens, and case fatality (117 studies). RESULTS: The most significant predictor of PCP was per capita Gross Domestic Product, which showed strong linear association with odds of PCP diagnosis (p<0.0001). This was not explained by study design or diagnostic quality. Geographical area, population age, study setting and year of study also contributed to risk of PCP. Co-infection was common (444 episodes/1425 PCP cases), frequently with virulent organisms. The predictive value of symptoms, signs or simple tests in LMIC settings for diagnosis of PCP was poor. Case fatality was >30%; treatment was largely appropriate. Prophylaxis appeared to reduce the risk for development of PCP, however 24% of children with PCP were receiving prophylaxis. CD4 counts at presentation with PCP were usually <200×10(3/)ml. CONCLUSIONS: There is a positive relationship between GDP and risk of PCP diagnosis. Although failure to diagnose infection in poorer countries may contribute to this, we also hypothesise that poverty exposes at-risk patients to a wide range of infections and that the relatively non-pathogenic P. jirovecii is therefore under-represented. As LMIC develop economically they eliminate the conditions underlying transmission of virulent infection: P. jirovecii, ubiquitous in all settings, then becomes a greater relative threat.
format Online
Article
Text
id pubmed-3732248
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37322482013-08-09 Pneumocystis jirovecii Pneumonia in Tropical and Low and Middle Income Countries: A Systematic Review and Meta-Regression Lowe, David M. Rangaka, Molebogeng X. Gordon, Fabiana James, Chris D. Miller, Robert F. PLoS One Research Article OBJECTIVE: Pneumocystis jirovecii pneumonia (PCP), the commonest opportunistic infection in HIV-infected patients in the developed world, is less commonly described in tropical and low and middle income countries (LMIC). We sought to investigate predictors of PCP in these settings. DESIGN: Systematic review and meta-regression. METHODS: Meta-regression of predictors of PCP diagnosis (33 studies). Qualitative and quantitative assessment of recorded CD4 counts, receipt of prophylaxis and antiretrovirals, sensitivity and specificity of clinical signs and symptoms for PCP, co-infection with other pathogens, and case fatality (117 studies). RESULTS: The most significant predictor of PCP was per capita Gross Domestic Product, which showed strong linear association with odds of PCP diagnosis (p<0.0001). This was not explained by study design or diagnostic quality. Geographical area, population age, study setting and year of study also contributed to risk of PCP. Co-infection was common (444 episodes/1425 PCP cases), frequently with virulent organisms. The predictive value of symptoms, signs or simple tests in LMIC settings for diagnosis of PCP was poor. Case fatality was >30%; treatment was largely appropriate. Prophylaxis appeared to reduce the risk for development of PCP, however 24% of children with PCP were receiving prophylaxis. CD4 counts at presentation with PCP were usually <200×10(3/)ml. CONCLUSIONS: There is a positive relationship between GDP and risk of PCP diagnosis. Although failure to diagnose infection in poorer countries may contribute to this, we also hypothesise that poverty exposes at-risk patients to a wide range of infections and that the relatively non-pathogenic P. jirovecii is therefore under-represented. As LMIC develop economically they eliminate the conditions underlying transmission of virulent infection: P. jirovecii, ubiquitous in all settings, then becomes a greater relative threat. Public Library of Science 2013-08-02 /pmc/articles/PMC3732248/ /pubmed/23936365 http://dx.doi.org/10.1371/journal.pone.0069969 Text en © 2013 Lowe et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Lowe, David M.
Rangaka, Molebogeng X.
Gordon, Fabiana
James, Chris D.
Miller, Robert F.
Pneumocystis jirovecii Pneumonia in Tropical and Low and Middle Income Countries: A Systematic Review and Meta-Regression
title Pneumocystis jirovecii Pneumonia in Tropical and Low and Middle Income Countries: A Systematic Review and Meta-Regression
title_full Pneumocystis jirovecii Pneumonia in Tropical and Low and Middle Income Countries: A Systematic Review and Meta-Regression
title_fullStr Pneumocystis jirovecii Pneumonia in Tropical and Low and Middle Income Countries: A Systematic Review and Meta-Regression
title_full_unstemmed Pneumocystis jirovecii Pneumonia in Tropical and Low and Middle Income Countries: A Systematic Review and Meta-Regression
title_short Pneumocystis jirovecii Pneumonia in Tropical and Low and Middle Income Countries: A Systematic Review and Meta-Regression
title_sort pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732248/
https://www.ncbi.nlm.nih.gov/pubmed/23936365
http://dx.doi.org/10.1371/journal.pone.0069969
work_keys_str_mv AT lowedavidm pneumocystisjiroveciipneumoniaintropicalandlowandmiddleincomecountriesasystematicreviewandmetaregression
AT rangakamolebogengx pneumocystisjiroveciipneumoniaintropicalandlowandmiddleincomecountriesasystematicreviewandmetaregression
AT gordonfabiana pneumocystisjiroveciipneumoniaintropicalandlowandmiddleincomecountriesasystematicreviewandmetaregression
AT jameschrisd pneumocystisjiroveciipneumoniaintropicalandlowandmiddleincomecountriesasystematicreviewandmetaregression
AT millerrobertf pneumocystisjiroveciipneumoniaintropicalandlowandmiddleincomecountriesasystematicreviewandmetaregression